Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Juries hit Mead Johnson and Abbott Laboratories with verdicts of $60 million and $495 million respectively earlier this year ...

Jeff Kauflin is a senior editor who leads Forbes’ fintech coverage, covering everything from digital banking and investing to payments and insurtech. He co-edits Forbes’ annual Fintech 50 and ...

What to Watch: In Theaters and On Streaming. Link to What to Watch: In Theaters and On Streaming.

London | Jeff Bezos, the world’s second-richest man, is facing criticism from staff at The Washington Post following the newspaper’s decision not to endorse a presidential candidate for the ...

Jeff Conway is a dedicated entertainment interviewer and writer. Since joining Forbes four years ago, he has booked exclusive conversations with industry titans like Jennifer Aniston, Julie ...

A high ranking former editor at the Washington Post is claiming that the paper’s billionaire owner, Jeff Bezos, entered into a quid-pro-quo agreement with former President Donald Trump to kill ...

LINCOLN, Neb. (KOLN) - Governor Jim Pillen on Friday announced Nebraska Supreme Court Justice Jeffrey J. Funke as the state’s next Chief Justice, marking what Pillen called a “historic day.” ...

Abbott Laboratories' estimated fair value is US$127 based on 2 Stage Free Cash Flow to Equity Abbott Laboratories' US$117 share price indicates it is trading at similar levels as its fair value ...

For exclusive news and updates, subscribe to our Survivor Newsletter: [Warning: The following contains MAJOR spoilers for the Survivor Season 47 Episode 6.] The sixth episode of Season 47 ...

Abbott Laboratories, a healthcare giant with diverse divisions, is normalizing post-pandemic as its medical devices drive growth following a drop in Covid-test demand. The company reported 9% ...

Abbott Laboratories (ABT) stock has had negative returns for the last 3 years. But don’t get fooled by that when analyzing the stock’s performance. For a dividend aristocrat, one needs to look ...